Baird lowered the firm’s price target on Merit Medical (MMSI) to $103 from $112 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target lowered to $105 from $110 at Piper Sandler
- Merit Medical Systems: Strong Q2 Performance and Strategic Initiatives Justify Buy Rating
- Merit Medical Board Members’ Trading Plans: A Signal of Insider Intentions and Market Impact?
- Merit Medical Sees Strong Q2 Revenue Growth
- Merit Medical Systems Reports Strong Q2 2025 Results